| QIAGEN NV EO -,01 |
| Niederlande |
| Gesundheit |
| NL0015002SN0 / A41HBE |
| QIA (Frankfurt) / QGEN (NYSE) |
| FRA:QIA, ETR:QIA, QIA:GR, NYSE:QGEN |
| https://www.qiagen.com/ |
|
Qiagen N.V. is a biotechnology company that provides Sample to Insight solutions for molecular diagnostics, applied testing, academic research, and pharmaceutical research. Qiagen develops and markets sample preparation products, assay technologies, ..
>Volltext.. |
| 7774.51 Mio. EUR |
| 8518.33 Mio. EUR |
| 1828.75 Mio. EUR |
| 626.31 Mio. EUR |
| 356.38 Mio. EUR |
| 1.73 EUR |
| 1431.07 Mio. EUR |
| 669.12 Mio. EUR |
| 569.84 Mio. EUR |
| 1.36 |
| 6.19% |
| 13.07% |
| 2.49 EUR |
| 0.79% |
| 0.79% |
| 07.07.26 - 0.30653€ 08.01.26 - 2.180130526316€ >weitere anzeigen... |
| - |
| QIAGEN |
| 22.09.26 |
|
||||
|
||||
|